Clinical Trial Update: A Study to Assess the Safety and Effectiveness of Palivizumab Administered to Children at High Risk of Severe Respiratory Syncytial Virus (RSV) Infection in the Russian Federation and the Republic of Belarus [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the safety and effectiveness of palivizumab in high-risk children for RSV infection in Russia and Belarus; the trial is completed and r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• Palivizumab (Palivizumab)

Snippet

Sponsor: AbbVie | Conditions: Respiratory Syncytial Virus (RSV) | Phase 3 | Status: COMPLETED | Results posted: 2018-03-13